MedPath

Investigating the effect of a novel discourse intervention on everyday communication in people with dementia.

Not Applicable
Conditions
Dementia
Primary progressive aphasia
Neurological - Dementias
Physical Medicine / Rehabilitation - Speech therapy
Registration Number
ACTRN12621000664842
Lead Sponsor
Curtin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

(1) clinical diagnosis of a dementia syndrome (i.e. major neurocognitive disorder, DSM-5), including Alzheimer’s disease, frontotemporal dementia and/or PPA or progressive language impairment (e.g. complaints of word finding and/or communication difficulties that are worsening over time), (2) early to moderate stage of disease progression as determined by the MMSE (13-25 points) or ACE-III (38-88 points; So et al., 2018), noting that cut off criteria may be adjusted for each participant based on their age and years of education in consultation with their medical specialist, (3) capacity to consent to participation as determined by their treating medical specialist, (4) normal or corrected hearing and vision, and (5) proficient in English (used English in everyday communication [no interpreter required for therapy]).

Exclusion Criteria

(1) severe dementia (MMSE < 13; ACE-III <38; So et al., 2018), (2) primary impairment of apraxia of speech (AoS) or dysarthria, (3) a prior diagnosis of stroke, head injury or neurosurgery, and (4) clinically diagnosed major depression.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measures involve analysis of Correct Information Units (CIUs) of language samples.<br><br>The first primary outcome measure is informativeness [%CIUs]<br><br>[Pre treatment baseline period (week 1 and 2)<br>Immediately post treatment (week 13)<br>Follow up (week 17)];The second primary outcome measure is efficiency [CIUs/min] of information communicated. <br><br>Analysis of CIUs has a long history and evidence base of use within the aphasia and dementia fields. [Pre treatment baseline period (week 1 and 2)<br>Immediately post treatment (week 13)<br>Follow up (week 17)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath